Leupaxin acts as a mediator in prostate carcinoma progression through deregulation of p120catenin expression.
Autor: | Kaulfuß, S.1 svoigt1@gwdg.de, von Hardenberg, S.1, Schweyer, S.2, Herr, A. M.1, Laccone, F.3, Wolf, S.1, Burfeind, P.1 |
---|---|
Zdroj: | Oncogene. 11/12/2009, Vol. 28 Issue 45, p3971-3982. 12p. 8 Graphs. |
Databáze: | Academic Search Ultimate |
Externí odkaz: |